Voronoi · 16 hours ago
Clinical Scientist / Senior-to-director Oncology
Boston, MA
Full-time
Hybrid
Senior Level, Lead/Staff, Director/Executive
10+ years expVoronoi, Inc. is a clinical-stage biopharmaceutical company developing innovative, precision-targeted therapies in oncology. The Clinical Scientist / Senior-to-Director will serve as a key scientific member of the Clinical Development team, providing scientific and operational contributions across clinical studies and ensuring the design, execution, and reporting of high-quality clinical trials.
BiotechnologyHealth Care
Responsibilities
Contribute to the design, implementation, and reporting of early phase oncology trials
Lead authoring and review of clinical documents including study protocols, investigator brochures, clinical study reports (CSRs), and informed consent forms
Participate in medical data review, safety surveillance, and preparation of interim and final study analyses
Ensure consistency of scientific messaging across study documents, publications, and presentations
Partner with Clinical Operations, Biostatistics, Regulatory Affairs, and Translational Science to ensure data quality and scientific integrity
Support preparation of regulatory submissions and responses
Contribute to KOL engagement and investigator interactions as part of clinical team representation
Summarize and interpret emerging efficacy and safety data for internal meetings and external dissemination
Support preparation of abstracts, posters, and manuscripts for scientific conferences
Mentor junior team members and contribute to the continuous improvement of Clinical Science processes
Qualification
Preferred
PhD, PharmD, or MD in a life-science discipline strongly preferred
Master's degree with significant oncology development experience will be considered
8–12+ years of clinical development experience in oncology within a biopharma or biotech setting
Hands-on experience with protocol development, data review, CSR preparation, and cross-functional study team participation
Familiarity with GCP, ICH, and global regulatory guidelines (FDA/EMA)
Strong communication skills with ability to convey complex scientific concepts clearly
Proven ability to work effectively in a global, matrixed, fast-paced environment
Company
Voronoi
Voronoi is a biotech company that develops novel kinase inhibitors and target protein degraders.
51-200 employees
Funding
Current Stage
Growth StageTotal Funding
$1.06BKey Investors
Nice Investment Partners
2019-04-18Series Unknown· $1.06B
Recent News
2025-04-02
2025-04-02
2025-04-02
Company data provided by crunchbase